Breast cancer (Dove Medical Press)

Keyphrases

Publications

volume 16, 2024

Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu, Yi-Xin Qi
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Yuying Zhou, Wu Xue, Xinyu Meng, Adheesh Bhandari, Hanqian Zeng, Rajan Kc, Suzita Hirachan, Erjie Xia
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Nelson Rangel, Iris Lorena Sánchez, Duván Sebastián Valbuena, Milena Rondón-Lagos
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Yong-Hong Zhou, Jian-Yuan Huang
Expression and Significance of LINC02418 in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Fardeen Bhimani, Sophie Lin, Maureen McEvoy, Arianna Cavalli, Liane Obaid, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Areej Shihabi, Sheldon Feldman
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study. Breast cancer (Dove Medical Press) 16 (2024)
Meixi Ye, Hao Xu, Jinhua Ding, Li Jiang
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review. Breast cancer (Dove Medical Press) 16 (2024)
Shuling Wang, Yuqin Chen, Weidong Li, Chunfang Hao, Li Zhang, Weipeng Zhao, Yehui Shi, Zhongsheng Tong
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients. Breast cancer (Dove Medical Press) 16 (2024)
Michelle Marie Ubowski, Ryan VanSice, Morgan Marriott, Matthew J Yacobucci, Lipika Chablani
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Qi Li, Cong Gao, Xinrui Zhao, Jiahui Li, Qinghong Shen, Li Chen
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery. Breast cancer (Dove Medical Press) 16 (2024)
Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fêde, Gustavo de Oliveira Bretas, Cristiano de Pádua Souza, Max Mano, Jessé Lopes da Silva
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast cancer (Dove Medical Press) 16 (2024)
Seid Fentaw, Anteneh Asmare Godana, Dawit Abathun, Dessie Melese Chekole
Comparative Analysis of Women's Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia's Amhara Region Using Parametric Shared Frailty Models. Breast cancer (Dove Medical Press) 16 (2024)
Jian Jin, Jie Li, Yonghong Liu, Qingfeng Shi, Bo Zhang, Yanting Ji, Pengfei Hu
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Qingqing Gu, Mingzhi Zhu, Yanyan Wang, Yuanting Gu
Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab. Breast cancer (Dove Medical Press) 16 (2024)
Febie Irsandy Syahruddin, null Prihantono, Mirna Muis
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]. Breast cancer (Dove Medical Press) 16 (2024)
Yong-Hong Zhou, Jian-Yuan Huang
Expression and Significance of LINC02418 in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Meixi Ye, Hao Xu, Jinhua Ding, Li Jiang
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review. Breast cancer (Dove Medical Press) 16 (2024)
Meixi Ye, Hao Xu, Jinhua Ding, Li Jiang
Therapy for Hormone Receptor-Positive, Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer Following Treatment Progression via CDK4/6 Inhibitors: A Literature Review. Breast cancer (Dove Medical Press) 16 (2024)
Katleen Nobbe, Melanie Erices-Leclercq, Frank Foerster, Robert Förster, Stephan E Baldus, Christian Rudlowski, Lars Schröder, Sabine Lubig
HER2 Low Expression in Primary Male Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Weiwei Xiao, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial. Breast cancer (Dove Medical Press) 16 (2024)
Sarah Sharman Moser, Lior Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, Gabriel Chodick, Nava Siegelmann-Danieli
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting. Breast cancer (Dove Medical Press) 16 (2024)
Yuying Zhou, Wu Xue, Xinyu Meng, Adheesh Bhandari, Hanqian Zeng, Rajan Kc, Suzita Hirachan, Erjie Xia
GNPNAT1 is a Biomarker That Predicts a Poor Prognosis of Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Mariana Ribeiro Monteiro, Natalia Cristina Cardoso Nunes, Aumilto Augusto da Silva Junior, Angelo Bezerra de Souza Fêde, Gustavo de Oliveira Bretas, Cristiano de Pádua Souza, Max Mano, Jessé Lopes da Silva
Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast cancer (Dove Medical Press) 16 (2024)
Qin Ma, Yao-Bang Liu, Tong She, Xin-Lan Liu
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients. Breast cancer (Dove Medical Press) 16 (2024)
Chia-Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu, Ching-Ting Wei
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Chia-Chi Chen, Wei-Hua Tang, Cheng-Ching Wu, Thung-Lip Lee, I-Ting Tsai, Chin-Feng Hsuan, Chao-Ping Wang, Fu-Mei Chung, Yau-Jiunn Lee, Teng-Hung Yu, Ching-Ting Wei
Pretreatment Circulating Albumin, Platelet, and RDW-SD Associated with Worse Disease-Free Survival in Patients with Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Li Guo, Shi-Cui Hong, Xuan Wang, Sheng-Qi Wang, Neng Wang, Xiao-Qing Wei, Hong-Lin Situ, Zhi-Yu Wang
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial. Breast cancer (Dove Medical Press) 16 (2024)
Suheyla Ekemen, Ebru Bilir, Hagar Elsayed Akram Soultan, Sadia Zafar, Figen Demir, Babek Tabandeh, Sadik Toprak, Ozlem Yapicier, Cevayir Coban
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors. Breast cancer (Dove Medical Press) 16 (2024)
Seid Fentaw, Anteneh Asmare Godana, Dawit Abathun, Dessie Melese Chekole
Comparative Analysis of Women's Breast Cancer Survival Time at Three Selected Government Referral Hospitals in Ethiopia's Amhara Region Using Parametric Shared Frailty Models. Breast cancer (Dove Medical Press) 16 (2024)
Qingqing Gu, Mingzhi Zhu, Yanyan Wang, Yuanting Gu
Retrospective Analysis of Pyrotinib-Based Therapy for Metastatic Breast Cancer: Promising Efficacy in Combination with Trastuzumab. Breast cancer (Dove Medical Press) 16 (2024)
Li Guo, Shi-Cui Hong, Xuan Wang, Sheng-Qi Wang, Neng Wang, Xiao-Qing Wei, Hong-Lin Situ, Zhi-Yu Wang
Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial. Breast cancer (Dove Medical Press) 16 (2024)
Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu, Yi-Xin Qi
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Xulei Sui, Peipei Feng, Xiaoyuan Sun, Peng Liang, Ying Liu, Guowei Zhang
Correlation Analysis of Digital Mammography, Ultrasonography, and Pathologic Features in Pure Invasive Micropapillary Carcinoma of the Breast (PIMPC). Breast cancer (Dove Medical Press) 16 (2024)
Shen Ma, Ran Hao, Yi-Wei Lu, Hui-Po Wang, Jie Hu, Yi-Xin Qi
Identification and Validation of Novel Metastasis-Related Immune Gene Signature in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Zhitao Zhang, Huan Lan, Shuai Zhao
Analysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis. Breast cancer (Dove Medical Press) 16 (2024)
Febie Irsandy Syahruddin, null Prihantono, Mirna Muis
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]. Breast cancer (Dove Medical Press) 16 (2024)
Ying Chen, Wen-Xia Li, Jia-Hua Wu, Geng-Hang Chen, Chun-Min Yang, Hai Lu, Xi Wang, Shu-Sen Wang, Heng Huang, Li Cai, Li Zhao, Rou-Jun Peng, Ying Lin, Jun Tang, Jian Zeng, Le-Hong Zhang, Yong-Li Ke, Xian-Ming Wang, Xin-Mei Liu, An-Qin Zhang, Fei Xu, Xi-Wen Bi, Jia-Jia Huang, Weiwei Xiao, Dan-Mei Pang, Cong Xue, Yan-Xia Shi, Zhen Yu He, Huan-Xin Lin, Xin An, Wen Xia, Ye Cao, Ying Guo, Ruo-Xi Hong, Kui-Kui Jiang, Yong-Yi Zhong, Ge Zhang, Piyawan Tienchaiananda, Masahiro Oikawa, Zhong-Yu Yuan, Qian-Jun Chen
Does the Dose of Standard Adjuvant Chemotherapy Affect the Triple-negative Breast Cancer Benefit from Extended Capecitabine Metronomic Therapy? An Exploratory Analysis of the SYSUCC-001 Trial. Breast cancer (Dove Medical Press) 16 (2024)
Shuling Wang, Yuqin Chen, Weidong Li, Chunfang Hao, Li Zhang, Weipeng Zhao, Yehui Shi, Zhongsheng Tong
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients. Breast cancer (Dove Medical Press) 16 (2024)
Febie Irsandy Syahruddin, null Prihantono, Mirna Muis
Serum HER2 Level Predicts Therapeutic Efficacy and Prognosis in Advanced Breast Cancer Patients [Letter]. Breast cancer (Dove Medical Press) 16 (2024)
Michelle Marie Ubowski, Ryan VanSice, Morgan Marriott, Matthew J Yacobucci, Lipika Chablani
Amplifying Immune Responses: Microparticulate Vaccine Approach Against Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Katleen Nobbe, Melanie Erices-Leclercq, Frank Foerster, Robert Förster, Stephan E Baldus, Christian Rudlowski, Lars Schröder, Sabine Lubig
HER2 Low Expression in Primary Male Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Nelson Rangel, Iris Lorena Sánchez, Duván Sebastián Valbuena, Milena Rondón-Lagos
ZNF217 Gene Copy Number as a Marker of Response to Standard Therapy Drugs According to ERα Status in Breast Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Zhitao Zhang, Huan Lan, Shuai Zhao
Analysis of the Value of Quantitative Features in Multimodal MRI Images to Construct a Radio-Omics Model for Breast Cancer Diagnosis. Breast cancer (Dove Medical Press) 16 (2024)
Sarah Sharman Moser, Lior Apter, Idit Livnat, Roni Ginsburg, Adva Yarden, Michal Drori, Anat Drizon, Gabriel Chodick, Nava Siegelmann-Danieli
Clinical Outcomes of Patients with HER2 Positive Metastatic Breast Cancer to the Brain, with First-Line Trastuzumab, Pertuzumab and Chemotherapy, in a Real-World Setting. Breast cancer (Dove Medical Press) 16 (2024)
Qi Li, Cong Gao, Xinrui Zhao, Jiahui Li, Qinghong Shen, Li Chen
An Analysis of Preoperative Inflammatory Indicators That Influence the Drainage Tube Retention Time in Patients with Breast Cancer Surgery. Breast cancer (Dove Medical Press) 16 (2024)
Mehmet Emin Buyukbayram, Zekeriya Hannarici, Yakup Duzkopru, Aykut Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, Mehmet Bilici, Salim Basol Tekin, Doğan Yazılıtaş
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker. Breast cancer (Dove Medical Press) 16 (2024)
Mehmet Emin Buyukbayram, Zekeriya Hannarici, Yakup Duzkopru, Aykut Turhan, Alperen Akansel Caglar, Pınar Coban Esdur, Mehmet Bilici, Salim Basol Tekin, Doğan Yazılıtaş
The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker. Breast cancer (Dove Medical Press) 16 (2024)
Qin Ma, Yao-Bang Liu, Tong She, Xin-Lan Liu
The Role of Ki-67 in HR+/HER2- Breast Cancer: A Real-World Study of 956 Patients. Breast cancer (Dove Medical Press) 16 (2024)
Fardeen Bhimani, Sophie Lin, Maureen McEvoy, Arianna Cavalli, Liane Obaid, Yu Chen, Anjuli Gupta, Jessica Pastoriza, Areej Shihabi, Sheldon Feldman
Does Nipple-Ward Positive Margin Contribute to a Higher Rate of Re-Excision Procedures After a Lumpectomy with Pathology-Confirmed Positive Margins? A Retrospective Study. Breast cancer (Dove Medical Press) 16 (2024)
Jian Jin, Jie Li, Yonghong Liu, Qingfeng Shi, Bo Zhang, Yanting Ji, Pengfei Hu
Thyroid Hormone Changes Correlate to Combined Breast Cancer with Primary Thyroid Cancer. Breast cancer (Dove Medical Press) 16 (2024)
Suheyla Ekemen, Ebru Bilir, Hagar Elsayed Akram Soultan, Sadia Zafar, Figen Demir, Babek Tabandeh, Sadik Toprak, Ozlem Yapicier, Cevayir Coban
The Programmed Cell Death Ligand 1 and Lipocalin 2 Expressions in Primary Breast Cancer and Their Associations with Molecular Subtypes and Prognostic Factors. Breast cancer (Dove Medical Press) 16 (2024)